long half-life and large variability [Regulatives / Guidelines]

posted by dshah  – India, 2020-08-10 08:18 (1527 d 21:03 ago) – Posting: # 21846
Views: 2,880

Hi All!

I believe there are few MR drug with high variability and still USFDA recommends partial or fully replicate design. Mesalamine PSG or
Mesalamine PSG for 800 mg strength
Considering the Mechanism of Action, PK variability, non-Linearity- the study and formultion could indeed be challenging.

Regards,
Dshah

Complete thread:

UA Flag
Activity
 Admin contact
23,258 posts in 4,886 threads, 1,661 registered users;
67 visitors (0 registered, 67 guests [including 9 identified bots]).
Forum time: 05:22 CEST (Europe/Vienna)

I’m not a pessimist,
I’m just a well informed optimist.    José Saramago

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5